De Ruysscher D, Ramalingam S, Urbanic J, Gerber DE, et al. CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-S Clin Lung Cancer 2021 Jul 19. pii: S1525-7304(21)00186.
PMID: 34489161